Roundtable: Outlining Model Validation & Establishing the Need for Standardization
Time: 9:15 am
day: Day Two
Details:
- How to effectively identify novel drug combinations on a limited experimental budget
- Common pitfalls in phenotypic drug combination screening analysis – can we move away from computed synergy scores
- Avoiding bias when evaluating drug combinations in vivo
